HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: CJN.05021107v1 3/2/471    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abecassis, M. Articles by Gaston, R. S. Search for Related Content PubMed PubMed Citation Articles by Abecassis, M. Articles by Gaston, R. S.

Kidney Transplantation as Primary Therapy for End-Stage Renal Disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI^TM) Conference

Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama

Correspondence: Dr. Robert S. Gaston, University of Alabama at Birmingham, Division of Nephrology, 625 THT, 1900 University Boulevard, Birmingham, AL 35294. Phone: 205-934-7220; Fax: 205-975-0102; E-mail: rgaston{at}uab.edu

Background and objectives: Kidney transplantation is the most desired and cost-effective modality of renal replacement therapy for patients with irreversible chronic kidney failure (end-stage renal disease, stage 5 chronic kidney disease). Despite emerging evidence that the best outcomes accrue to patients who receive a transplant early in the course of renal replacement therapy, only 2.5% of incident patients with end-stage renal disease undergo transplantation as their initial modality of treatment, a figure largely unchanged for at least a decade.

Design, setting, participants, & measurements: The National Kidney Foundation convened a Kidney Disease Outcomes Quality Initiative (KDOQI) conference in Washington, DC, March 19 through 20, 2007, to examine the issue. Fifty-two participants representing transplant centers, dialysis providers, and payers were divided into three work groups to address the impact of early transplantation on the chronic kidney disease paradigm, educational needs of patients and professionals, and finances of renal replacement therapy.

Results: Participants explored the benefits of early transplantation on costs and outcomes, identified current barriers (at multiple levels) that impede access to early transplantation, and recommended specific interventions to overcome those barriers.

Conclusions: With implementation of early education, referral to a transplant center coincident with creation of vascular access, timely transplant evaluation, and identification of potential living donors, early transplantation can be an option for substantially more patients with chronic kidney disease.

This article has been cited by other articles:

				R. Elias Confidentiality and consent in living kidney transplantation: is it essential for a donor to know that their recipient has HIV disease? Clin Ethics, December 1, 2009; 4(4): 202 - 207. [Abstract] [Full Text] [PDF]

				R. S. Gaston Must Health Literacy Be a Prerequisite for Kidney Transplantation? Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 16 - 17. [Full Text] [PDF]